Hu rau:Errol Zhou (Mr.)
Tel: ntxiv 86-551-65523315
Mobile/WhatsApp: ntxiv 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Email:sales@homesunshinepharma.com
Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj
CAS TSIS TAU: 1018899-04-1
Cov Qauv Nqaij: C21H25ClO5S
Cov Nqa Molecular: 424.93800
EINECS TSIS MUAJ: 805-113-6
MDL TSIS TAU: MFCD22493506
Khoom Qhia:
Khoom npe: Sotagliflozin CAS TSIS: 1018899-04-1
Txhais:
LX4211;
LX4211 / LX-4211;
Tshuaj& Cov Khoom Uas Lub Cev:
Zog: Cov khoom siv hluav taws xob
Ntsuas: ≥98.0%
Qhov ceev: 1.37 ± 0.1 g / cm3 (Pom zoo)
Cov ntsiab lus npau npau ： 607.9 ± 55.0 ℃ (Teem Tau)
PKa: 12.87 ± 0.70 (Teem Tau)
Cov Ntaub Ntawv Kev Nyab Xeeb:
Cia: -20 ℃
Kev Xa Khoom: Chav Chav Chav kub nyob hauv Asmeskas txuas ntxiv; tej zaum yuav hloov rau lwm qhov
Kev ruaj khov: ≥ 2 xyoos
LX-4211 yog ib qho inhibitor ntawm SGLT1 / 2 thiab yog tus neeg sawv cev tawm tsam. LX-4211 yog cov tshuaj kho mob ntshav qab zib hauv qhov ncauj tsim los ntawm Sanofi thiab Lescon Pharmaceuticals. Raws li dual inhibitor ntawm SGLT-1 thiab SGLT-2, cov tshuaj muaj peev xwm txo cov ntshav qab zib tom qab, nce GLP-1 thiab txhawb kev tso zis tawm ntawm lub siab.
Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!
Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.
Cim npe nrov: sotagliflozin cas 1018899-04-1, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag
